Company Filing History:
Years Active: 2024
Title: Dovile Zilenaite: Innovator in Tumor-Stroma Interface Detection
Introduction
Dovile Zilenaite is a prominent inventor based in Vilnius, Lithuania. She has made significant contributions to the field of cancer research through her innovative methods in tumor-stroma interface detection. Her work aims to enhance the assessment of anti-tumor responses, ultimately improving patient outcomes.
Latest Patents
Dovile Zilenaite holds a patent for her invention titled "Automated Tumour-Stroma interface zone detection for anti-tumour response assessment by immunogradient indicators." This groundbreaking method utilizes microscopy image analysis to automatically sample the tumor/stroma interface zone. The process involves delineating the tumor edge using explicit rules and sampling the interface zone to compute TIL density profiles. The novel Immunogradient indicators derived from this data have shown strong prognostic value in predicting overall patient survival in cohorts of breast and colorectal cancer patients.
Career Highlights
Zilenaite's career is marked by her dedication to advancing cancer research. She is affiliated with Vilnius University, where she continues to develop and refine her innovative methodologies. Her work has garnered attention for its potential to provide precise spatial immune response measurements in tumor-host interactions.
Collaborations
Dovile Zilenaite collaborates with esteemed colleagues, including Arvydas Laurinavicius and Allan Rasmusson. Their combined expertise contributes to the advancement of research in the field of oncology.
Conclusion
Dovile Zilenaite's contributions to tumor-stroma interface detection represent a significant advancement in cancer research. Her innovative methods and dedication to improving patient outcomes highlight the importance of continued research in this critical area.